Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL)

CUSIP: 05280R100

Q1 2022 13F Holders as of 31 Mar 2022

Security identity
Shares outstanding
266,837,198
Security type / class
Equity / Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share
Holder snapshot
Total 13F shares
45,661,103
Share change
-3,193,790
Total reported value
$190,513,250
Put/Call ratio
0%
Reported price per share
$4.17
Number of holders
60
Value change
-$17,791,387
Number of buys
24
Number of sells
39

Security key

05280R100

Report period

Q1 2022

Institutions

60

Top holders

10

AUTL full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2022 Previous quarter: Q4 2021 Autolus Therapeutics plc SEC filings Autolus Therapeutics plc company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of AUTL - Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
Blackstone Inc.
13D/G signal
—
Evidence rows
15
Latest as of
31 Dec 2021
13F Lead comparable stake: 6.7% Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
Blackstone Inc.
13F
Company
13F
6.7%
$93,345,000
17,985,611 shares
 — 31 Dec 2021
Syncona Portfolio Ltd
13F
Company
13F
2.8%
$38,130,000
7,346,829 shares
 — 31 Dec 2021
Nantahala Capital Management, LLC
13F
Company
13F
1.5%
$21,162,000
4,077,509 shares
 — 31 Dec 2021
FRAZIER MANAGEMENT LLC
13F
Company
13F
1.4%
$19,446,000
3,746,857 shares
 — 31 Dec 2021
Capital World Investors
13F
Company
13F
1.1%
$15,341,000
2,955,806 shares
 — 31 Dec 2021
Tetragon Partners GP Ltd
13F
Company
13F
1%
$14,013,000
2,700,000 shares
 — 31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
60
Shares
45,661,103
Rows available
60
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders
69
Q1 2022 holders
60
Holder diff
-9
Investor Q4 2021 Shares Q1 2022 Shares Share Diff Share Chg % Q4 2021 value Q1 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .